Richard E. Hurteau
443-***-**** - North East, MD
***************@*****.***
** *****’ experience as a chemist with diverse backgrounds
AREAS OF EXPERTISE
●Design and execution of experiments to support research and development
●Expertise in HPLC, LC/MS, GC, GC/MS hardware and software, plate readers, bioassays and other lab equipment
●Over 10 years of QC analysis of raw materials, intermediates and final products as well as HPLC columns
●Purification of polysaccharides and reaction products using Åkta equipment and Unicorn software, including column packing.
●TFF separation of monosaccharides from polysaccharides
●Characterization of enzyme libraries
●Analysis and presentation of complex data using Power Point and Excel.
●Analytical method development and troubleshooting of existing methods.
●Process chemistry development and improvement.
●Multitasking in fast paced environments.
●Analytical support to formulation scientists and other non-chemists
●Training of chemists and non-chemists
●Generation of data to support IP filings.
●Set-up and management of laboratories
●Purification and analysis of monoclonal antibodies.
Venatorx Pharmaceuticals, Malvern, Pa February 2021 – current
through Actalent
Analytical chemistry consultant
●Developed HPLC and LC/MS methods to help solve technical issues for successful launch of pharmaceutical products.
●Analytical support for formulation group.
DUPONT, Wilmington, DE 2019 – 2021
through Ampcus
Associate Scientist
●Conducted over 100 experiments to support Kalrez team projects including raw material analysis, organic fluorochemical synthesis, distillations, isolation and purification of products and analytes of interest.
●Characterization of raw materials, intermediates and reaction products by GC, GC/MS, NMR and FTIR spectroscopy.
●Process chemistry optimization.
●Analytical support and method development using GC, LC and GC/MS.
Agilent Technologies, Wilmington, DE 2016 – 2018
through Apex Life Sciences
HPLC Applications Chemist
●Characterization of HPLC columns (e.g. Affinity, Peptide Mapping, IEX, HILIC, SEC, reversed phase, etc.) utilizing Agilent HPLCs to generate and interpret scientific data to improve existing products and compare to competitor’s products analyzing biopharma biomolecules and pharmaceutical small molecules.
●Generation and presentation of critical data utilizing Excel and PowerPoint to support field engineers, marketing and sales teams.
Richard Hurteau Page - 2
●Extensive HPLC and LC/MS method development, trouble shooting, maintenance and minor repairs of instruments.
●Troubleshooting of problems with HPLC columns for customers. Evaluated OEM columns for manufacturing.
●Published three application notes on Agilent’s website (including one on SEC method development (https://www.agilent.com/cs/library/applications/application-sec-biopharma-and-therapeutic-proteins-advancebio-sec-5994-0154en-agilent.pdf).
DUPONT, Wilmington, DE 2007 – 2016
Staff Scientist/Associate Investigator Industrial Biosciences (IB)
●Performed chemical reactions and reaction product purifications to produce oligosaccharide samples for further characterization by LC, GC/MS, NMR, SEC and other test methods. Maintained and collated extensive experimental data in electronic laboratory notebooks.
●Generated experimental data to optimize reaction conditions to meet customer CTQs and economic targets. Including scale up from bench using HPLC and FPLC instruments.
●FPLC method development (IEC and SEC) utilizing GE Åkta instruments and software to purify biomolecules on bench and pilot scale levels to support commercial scale operations. TFF purification of biomolecules.
●Performed calibrations and routine maintenance on lab instruments (HPLC, GC, UV-VIS).
●Food grade separations of oligosaccharides from mono and di-saccharides for evaluation in sensory panel evaluations.
●Participated in meetings with external business partners and internal business team members to help direct research and development to meet customer CTQs and to leverage DuPont technologies to other market applications.
●Managed two labs with minimal supervision, ordered all lab equipment and supplies.
●Trained new employees and molecular biologists to operate HPLCs and perform laboratory procedures in a safe manner.
●Wet chemistry methods, including but not limited to, rotary evaporators, lyophilizers to make complex samples for product characterization, and complex derivatization procedures.
●Presented data to colleagues in bi-monthly meetings utilizing Power Point. Wrote monthly technical and annual reports.
●Characterized enzyme libraries of wild-type and genetically modified enzymes to determine enzyme candidate performance in laundry, medical device sanitization and food applications and processes.
●Participated in and presented posters on research at internal technical conferences.
●Utilized knowledge obtained from internal business and finance courses taken at DuPont to provide input on the economic benefits of selecting enzymes and reaction conditions.
●Characterization of enzymes in research applications set by customers CTQs.
●Analysis and experimental input of scientific design of experiments (DOEs) for formulations and stability testing.
● Richard Hurteau Page - 3 -
CIBA SPECIALTY CHEMICALS, Newport, DE 1999 – 2006
Quality Control Chemist
●Performed time critical analyses of raw materials, chemical intermediates and final products using GC, HPLC, UIV-Vis spectroscopy, Karl Fisher analysis and wet chemistry to support plant production of pigments.
●Managed lab and all performed all analyses on night shift with no supervision.
EDUCATION
BS, Chemistry - Saint Joseph’s University, Philadelphia.
PROFESSIONAL ACTIVITIES
●Six-Sigma Green Belt (2009).
●Poster presentations - TechCon, 2008, 2009, 2010, 2011, 2013 and 2015.
●Completed courses in economics for finance researchers and NPV determination of research projects.
●Served on hiring, promotion and safety committees.
●Completed Burgher writing course in technical writing.
●Won awards for travelling to St. Louis and Kantvik, Finland to support key business needs.
●Publications: Three Agilent application notes: one on the Agilent AdvanceBio MS Spent Media column, another on SEC method development, and one on SEC technology improvements.
●https://www.agilent.com/cs/library/applications/application-sec-biopharma-and-therapeutic-proteins-advancebio-sec-5994-0154en-agilent.pdf
●https://www.agilent.com/cs/library/applications/application-method-transfer-sec-5994-0625en-agilent.pdf
●https://www.agilent.com/cs/library/applications/application-saccharide-advancebio-ms-spent-media-5994-0320en-agilent.pdf